Glucose-lowering medications and the risk of cancer: a methodological review of studies based on real-world data.

摘要

Aim:Recent years have witnessed a proliferation of observational research examining the association between glucose-lowering medications and cancer, paired with an increasing concern on the quality of the produced evidence. Our objective was to review published studies in this area to identify the most common methodological challenges and sources of bias.